Total Intravenous Anesthesia (TIVA) versus Inhalational Anesthesia at The End of Laparoscopic Obstetric Surgery regarding postoperative nausea and vomiting

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202511762741637

Enrollment

Registered

2025-11-06

Start date

2025-11-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

total intravenous anaesthesia

Volatile end group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: a.Female, age 19–45years. c. Elective laparoscopic procedure under general anaesthesia with endotracheal intubation. d. Expected surgical duration = 30 minutes. e.Ability to consent and complete questionnaires.

Exclusion criteria

Exclusion criteria: Pregnancy or lactation. BMI = 40 kg/m²; severe cardiopulmonary disease; hepatic/renal failure. History of malignant hyperthermia or contraindication to study drugs. Known allergy to propofol, sevoflurane,or desflurane.

Design outcomes

Primary

Measure	Time frame
Incidence of post operative nausea and vomiting (0–24 h): Any episode of nausea (NRS = 4/10 or requiring treatment) and/or vomiting/retching recorded; need for rescue antiemetic. PONV Scoring System 1. Nausea (assessed by NRS 0–10) 0 ? No nausea 1–3 ? Mild nausea 4–6 ? Moderate nausea 7–10 ? Severe nausea 2. Vomiting Episodes 0 ? No vomiting 1 ? 1 episode 2 ? 2 episodes 3 ? =3 episodes	—

Secondary

Measure	Time frame
Time from end of surgery to extubation	—

Countries

Egypt

Contacts

Public ContactMohamed Ashraf

Resident of Anesthesia Intensive Care and Pain Management Faculty of medicine Assiut University

Mohamed.17289544@med.aun.edu.eg+201010143343

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026